Cinctive Capital Management LP Amicus Therapeutics, Inc. Transaction History

Cinctive Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$13.47 - $24.89 $2.96 Million - $5.46 Million	-219,524 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$12.89 - $15.89 $661,437 - $815,379	51,314 Added 30.51%	219,524 $3.1 Million
Q2 2020 Aug 14, 2020	SELL	$8.86 - $15.69 $959,954 - $1.7 Million	-108,347 Reduced 39.18%	168,210 $2.54 Million
Q1 2020 May 15, 2020	SELL	$6.63 - $11.16 $1.34 Million - $2.26 Million	-202,343 Reduced 42.25%	276,557 $2.56 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $3.58 Million - $5.15 Million	478,900 New	478,900 $4.66 Million

315

319M

378K

575K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $1.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.